▶ 調査レポート

アルテミシニン誘導体の世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Artemisinin Derivatives Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。アルテミシニン誘導体の世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Artemisinin Derivatives Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D005-02005資料のイメージです。• レポートコード:D005-02005
• 出版社/出版日:GlobalInfoResearch / 2020年5月22日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、103ページ
• 納品方法:Eメール
• 産業分類:化学・材料
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、アルテミシニン誘導体の世界市場を広く調査・分析し、今後の市場展望をまとめております。アルテミシニン誘導体の種類別市場規模(ジヒドロアルテミシニン、アルテミスネート、その他)、用途別市場規模(マラリア治療、科学研究、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Sanofi、Botanical Extracts EPZ Ltd、Guilin Pharmaceutical、KPC Pharmaceuticals、Novanat Bioresource、Guangxi Xiancaotang Pharmaceutical、Shanghai Natural Bio-engineering Co、Kerui Nanhai Pharmaceutical
・地域別グローバル市場分析 2015年-2020年
・アルテミシニン誘導体の北米市場(アメリカ、カナダ、メキシコ)
・アルテミシニン誘導体のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・アルテミシニン誘導体のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・アルテミシニン誘導体の南米市場(ブラジル、アルゼンチン)
・アルテミシニン誘導体の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:ジヒドロアルテミシニン、アルテミスネート、その他
・用途別分析:マラリア治療、科学研究、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Artemisinin Derivatives market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Artemisinin Derivatives market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Artemisinin Derivatives market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Artemisinin Derivatives market has been segmented into
Dihydroartemisinin
Artemisunate
Others

By Application, Artemisinin Derivatives has been segmented into:
Malaria Treatment
Scientific Research
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Artemisinin Derivatives market presented in the report. This section sheds light on the sales growth of different regional and country-level Artemisinin Derivatives markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Artemisinin Derivatives market.

The report offers in-depth assessment of the growth and other aspects of the Artemisinin Derivatives market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Artemisinin Derivatives Market Share Analysis
Artemisinin Derivatives competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Artemisinin Derivatives sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Artemisinin Derivatives sales, revenue and market share for each player covered in this report.

The major players covered in Artemisinin Derivatives are:
Sanofi
Botanical Extracts EPZ Ltd
Guilin Pharmaceutical
KPC Pharmaceuticals
Novanat Bioresource
Guangxi Xiancaotang Pharmaceutical
Shanghai Natural Bio-engineering Co
Kerui Nanhai Pharmaceutical

Among other players domestic and global, Artemisinin Derivatives market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Artemisinin Derivatives product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Artemisinin Derivatives, with price, sales, revenue and global market share of Artemisinin Derivatives in 2018 and 2019.
Chapter 3, the Artemisinin Derivatives competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Artemisinin Derivatives breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Artemisinin Derivatives market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Artemisinin Derivatives sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Artemisinin Derivatives Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Artemisinin Derivatives Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Dihydroartemisinin
1.2.3 Artemisunate
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Artemisinin Derivatives Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Malaria Treatment
1.3.3 Scientific Research
1.3.4 Others
1.4 Overview of Global Artemisinin Derivatives Market
1.4.1 Global Artemisinin Derivatives Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Artemisinin Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Botanical Extracts EPZ Ltd
2.2.1 Botanical Extracts EPZ Ltd Details
2.2.2 Botanical Extracts EPZ Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Botanical Extracts EPZ Ltd SWOT Analysis
2.2.4 Botanical Extracts EPZ Ltd Product and Services
2.2.5 Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Guilin Pharmaceutical
2.3.1 Guilin Pharmaceutical Details
2.3.2 Guilin Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Guilin Pharmaceutical SWOT Analysis
2.3.4 Guilin Pharmaceutical Product and Services
2.3.5 Guilin Pharmaceutical Artemisinin Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 KPC Pharmaceuticals
2.4.1 KPC Pharmaceuticals Details
2.4.2 KPC Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 KPC Pharmaceuticals SWOT Analysis
2.4.4 KPC Pharmaceuticals Product and Services
2.4.5 KPC Pharmaceuticals Artemisinin Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novanat Bioresource
2.5.1 Novanat Bioresource Details
2.5.2 Novanat Bioresource Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novanat Bioresource SWOT Analysis
2.5.4 Novanat Bioresource Product and Services
2.5.5 Novanat Bioresource Artemisinin Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Guangxi Xiancaotang Pharmaceutical
2.6.1 Guangxi Xiancaotang Pharmaceutical Details
2.6.2 Guangxi Xiancaotang Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Guangxi Xiancaotang Pharmaceutical SWOT Analysis
2.6.4 Guangxi Xiancaotang Pharmaceutical Product and Services
2.6.5 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Shanghai Natural Bio-engineering Co
2.7.1 Shanghai Natural Bio-engineering Co Details
2.7.2 Shanghai Natural Bio-engineering Co Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Shanghai Natural Bio-engineering Co SWOT Analysis
2.7.4 Shanghai Natural Bio-engineering Co Product and Services
2.7.5 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Kerui Nanhai Pharmaceutical
2.8.1 Kerui Nanhai Pharmaceutical Details
2.8.2 Kerui Nanhai Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Kerui Nanhai Pharmaceutical SWOT Analysis
2.8.4 Kerui Nanhai Pharmaceutical Product and Services
2.8.5 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Artemisinin Derivatives Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Artemisinin Derivatives Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Artemisinin Derivatives Manufacturer Market Share in 2019
3.3.2 Top 6 Artemisinin Derivatives Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Artemisinin Derivatives Sales, Revenue and Market Share by Regions
4.1.1 Global Artemisinin Derivatives Sales and Market Share by Regions (2015-2020)
4.1.2 Global Artemisinin Derivatives Revenue and Market Share by Regions (2015-2020)
4.2 North America Artemisinin Derivatives Sales and Growth Rate (2015-2020)
4.3 Europe Artemisinin Derivatives Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Artemisinin Derivatives Sales and Growth Rate (2015-2020)
4.5 South America Artemisinin Derivatives Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Artemisinin Derivatives Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Artemisinin Derivatives Sales, Revenue and Market Share by Country
5.1.1 North America Artemisinin Derivatives Sales and Market Share by Country (2015-2020)
5.1.2 North America Artemisinin Derivatives Revenue and Market Share by Country (2015-2020)
5.2 United States Artemisinin Derivatives Sales and Growth Rate (2015-2020)
5.3 Canada Artemisinin Derivatives Sales and Growth Rate (2015-2020)
5.4 Mexico Artemisinin Derivatives Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Artemisinin Derivatives Sales, Revenue and Market Share by Country
6.1.1 Europe Artemisinin Derivatives Sales and Market Share by Country (2015-2020)
6.1.2 Europe Artemisinin Derivatives Revenue and Market Share by Country (2015-2020)
6.2 Germany Artemisinin Derivatives Sales and Growth Rate (2015-2020)
6.3 UK Artemisinin Derivatives Sales and Growth Rate (2015-2020)
6.4 France Artemisinin Derivatives Sales and Growth Rate (2015-2020)
6.5 Russia Artemisinin Derivatives Sales and Growth Rate (2015-2020)
6.6 Italy Artemisinin Derivatives Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Artemisinin Derivatives Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Artemisinin Derivatives Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Artemisinin Derivatives Revenue and Market Share by Regions (2015-2020)
7.2 China Artemisinin Derivatives Sales and Growth Rate (2015-2020)
7.3 Japan Artemisinin Derivatives Sales and Growth Rate (2015-2020)
7.4 Korea Artemisinin Derivatives Sales and Growth Rate (2015-2020)
7.5 India Artemisinin Derivatives Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Artemisinin Derivatives Sales and Growth Rate (2015-2020)
7.7 Australia Artemisinin Derivatives Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Artemisinin Derivatives Sales, Revenue and Market Share by Country
8.1.1 South America Artemisinin Derivatives Sales and Market Share by Country (2015-2020)
8.1.2 South America Artemisinin Derivatives Revenue and Market Share by Country (2015-2020)
8.2 Brazil Artemisinin Derivatives Sales and Growth Rate (2015-2020)
8.3 Argentina Artemisinin Derivatives Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Artemisinin Derivatives Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Artemisinin Derivatives Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Artemisinin Derivatives Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Artemisinin Derivatives Sales and Growth Rate (2015-2020)
9.3 Turkey Artemisinin Derivatives Sales and Growth Rate (2015-2020)
9.4 Egypt Artemisinin Derivatives Sales and Growth Rate (2015-2020)
9.5 South Africa Artemisinin Derivatives Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Artemisinin Derivatives Sales and Market Share by Type (2015-2020)
10.2 Global Artemisinin Derivatives Revenue and Market Share by Type (2015-2020)
10.3 Global Artemisinin Derivatives Price by Type (2015-2020)
11 Global Artemisinin Derivatives Market Segment by Application
11.1 Global Artemisinin Derivatives Sales Market Share by Application (2015-2020)
11.2 Global Artemisinin Derivatives Revenue Market Share by Application (2015-2020)
11.3 Global Artemisinin Derivatives Price by Application (2015-2020)
12 Market Forecast
12.1 Global Artemisinin Derivatives Sales, Revenue and Growth Rate (2021-2025)
12.2 Artemisinin Derivatives Market Forecast by Regions (2021-2025)
12.2.1 North America Artemisinin Derivatives Market Forecast (2021-2025)
12.2.2 Europe Artemisinin Derivatives Market Forecast (2021-2025)
12.2.3 Asia-Pacific Artemisinin Derivatives Market Forecast (2021-2025)
12.2.4 South America Artemisinin Derivatives Market Forecast (2021-2025)
12.2.5 Middle East & Africa Artemisinin Derivatives Market Forecast (2021-2025)
12.3 Artemisinin Derivatives Market Forecast by Type (2021-2025)
12.3.1 Global Artemisinin Derivatives Sales Forecast by Type (2021-2025)
12.3.2 Global Artemisinin Derivatives Market Share Forecast by Type (2021-2025)
12.4 Artemisinin Derivatives Market Forecast by Application (2021-2025)
12.4.1 Global Artemisinin Derivatives Sales Forecast by Application (2021-2025)
12.4.2 Global Artemisinin Derivatives Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Artemisinin Derivatives Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Artemisinin Derivatives by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Artemisinin Derivatives Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Artemisinin Derivatives Major Business
Table 9. Sanofi Artemisinin Derivatives Total Revenue (USD Million) (2018-2019)
Table 10. Sanofi SWOT Analysis
Table 11. Sanofi Artemisinin Derivatives Product and Services
Table 12. Sanofi Artemisinin Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Botanical Extracts EPZ Ltd Basic Information, Manufacturing Base and Competitors
Table 14. Botanical Extracts EPZ Ltd Artemisinin Derivatives Major Business
Table 15. Botanical Extracts EPZ Ltd Artemisinin Derivatives Total Revenue (USD Million) (2018-2019)
Table 16. Botanical Extracts EPZ Ltd SWOT Analysis
Table 17. Botanical Extracts EPZ Ltd Artemisinin Derivatives Product and Services
Table 18. Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Guilin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Guilin Pharmaceutical Artemisinin Derivatives Major Business
Table 21. Guilin Pharmaceutical Artemisinin Derivatives Total Revenue (USD Million) (2018-2019)
Table 22. Guilin Pharmaceutical SWOT Analysis
Table 23. Guilin Pharmaceutical Artemisinin Derivatives Product and Services
Table 24. Guilin Pharmaceutical Artemisinin Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. KPC Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 26. KPC Pharmaceuticals Artemisinin Derivatives Major Business
Table 27. KPC Pharmaceuticals Artemisinin Derivatives Total Revenue (USD Million) (2018-2019)
Table 28. KPC Pharmaceuticals SWOT Analysis
Table 29. KPC Pharmaceuticals Artemisinin Derivatives Product and Services
Table 30. KPC Pharmaceuticals Artemisinin Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Novanat Bioresource Basic Information, Manufacturing Base and Competitors
Table 32. Novanat Bioresource Artemisinin Derivatives Major Business
Table 33. Novanat Bioresource Artemisinin Derivatives Total Revenue (USD Million) (2018-2019)
Table 34. Novanat Bioresource SWOT Analysis
Table 35. Novanat Bioresource Artemisinin Derivatives Product and Services
Table 36. Novanat Bioresource Artemisinin Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Guangxi Xiancaotang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 38. Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Major Business
Table 39. Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Total Revenue (USD Million) (2018-2019)
Table 40. Guangxi Xiancaotang Pharmaceutical SWOT Analysis
Table 41. Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Product and Services
Table 42. Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Shanghai Natural Bio-engineering Co Basic Information, Manufacturing Base and Competitors
Table 44. Shanghai Natural Bio-engineering Co Artemisinin Derivatives Major Business
Table 45. Shanghai Natural Bio-engineering Co Artemisinin Derivatives Total Revenue (USD Million) (2018-2019)
Table 46. Shanghai Natural Bio-engineering Co SWOT Analysis
Table 47. Shanghai Natural Bio-engineering Co Artemisinin Derivatives Product and Services
Table 48. Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Kerui Nanhai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 50. Kerui Nanhai Pharmaceutical Artemisinin Derivatives Major Business
Table 51. Kerui Nanhai Pharmaceutical Artemisinin Derivatives Total Revenue (USD Million) (2018-2019)
Table 52. Kerui Nanhai Pharmaceutical SWOT Analysis
Table 53. Kerui Nanhai Pharmaceutical Artemisinin Derivatives Product and Services
Table 54. Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Global Artemisinin Derivatives Sales by Manufacturer (2018-2019) (K MT)
Table 56. Global Artemisinin Derivatives Revenue by Manufacturer (2018-2019) (USD Million)
Table 57. Global Artemisinin Derivatives Sales by Regions (2015-2020) (K MT)
Table 58. Global Artemisinin Derivatives Sales Market Share by Regions (2015-2020)
Table 59. Global Artemisinin Derivatives Revenue by Regions (2015-2020) (USD Million)
Table 60. North America Artemisinin Derivatives Sales by Countries (2015-2020) (K MT)
Table 61. North America Artemisinin Derivatives Sales Market Share by Countries (2015-2020)
Table 62. North America Artemisinin Derivatives Revenue by Countries (2015-2020) (USD Million)
Table 63. North America Artemisinin Derivatives Revenue Market Share by Countries (2015-2020)
Table 64. Europe Artemisinin Derivatives Sales by Countries (2015-2020) (K MT)
Table 65. Europe Artemisinin Derivatives Sales Market Share by Countries (2015-2020)
Table 66. Europe Artemisinin Derivatives Revenue by Countries (2015-2020) (USD Million)
Table 67. Asia-Pacific Artemisinin Derivatives Sales by Regions (2015-2020) (K MT)
Table 68. Asia-Pacific Artemisinin Derivatives Sales Market Share by Regions (2015-2020)
Table 69. Asia-Pacific Artemisinin Derivatives Revenue by Regions (2015-2020) (USD Million)
Table 70. South America Artemisinin Derivatives Sales by Countries (2015-2020) (K MT)
Table 71. South America Artemisinin Derivatives Sales Market Share by Countries (2015-2020)
Table 72. South America Artemisinin Derivatives Revenue by Countries (2015-2020) (USD Million)
Table 73. South America Artemisinin Derivatives Revenue Market Share by Countries (2015-2020)
Table 74. Middle East & Africa Artemisinin Derivatives Sales by Countries (2015-2020) (K MT)
Table 75. Middle East & Africa Artemisinin Derivatives Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa Artemisinin Derivatives Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa Artemisinin Derivatives Revenue Market Share by Countries (2015-2020)
Table 78. Global Artemisinin Derivatives Sales by Type (2015-2020) (K MT)
Table 79. Global Artemisinin Derivatives Sales Share by Type (2015-2020)
Table 80. Global Artemisinin Derivatives Revenue by Type (2015-2020) (USD Million)
Table 81. Global Artemisinin Derivatives Revenue Share by Type (2015-2020)
Table 82. Global Artemisinin Derivatives Sales by Application (2015-2020) (K MT)
Table 83. Global Artemisinin Derivatives Sales Share by Application (2015-2020)
Table 84. Global Artemisinin Derivatives Sales Forecast by Regions (2021-2025) (K MT)
Table 85. Global Artemisinin Derivatives Market Share Forecast by Regions (2021-2025)
Table 86. Global Artemisinin Derivatives Sales Forecast by Type (2021-2025) (K MT)
Table 87. Global Artemisinin Derivatives Market Share Forecast by Type (2021-2025)
Table 88. Global Artemisinin Derivatives Sales Forecast by Application (2021-2025)
Table 89. Global Artemisinin Derivatives Market Share Forecast by Application (2021-2025)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Artemisinin Derivatives Picture
Figure 2. Global Sales Market Share of Artemisinin Derivatives by Type in 2019
Figure 3. Dihydroartemisinin Picture
Figure 4. Artemisunate Picture
Figure 5. Others Picture
Figure 6. Artemisinin Derivatives Sales Market Share by Application in 2018
Figure 7. Malaria Treatment Picture
Figure 8. Scientific Research Picture
Figure 9. Others Picture
Figure 10. Global Artemisinin Derivatives Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Artemisinin Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Artemisinin Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Artemisinin Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Artemisinin Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Artemisinin Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Artemisinin Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Artemisinin Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Artemisinin Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Artemisinin Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Artemisinin Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Artemisinin Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Artemisinin Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Artemisinin Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Artemisinin Derivatives Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Artemisinin Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Artemisinin Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Artemisinin Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Artemisinin Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Artemisinin Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Artemisinin Derivatives Sales Market Share by Manufacturer in 2019
Figure 31. Global Artemisinin Derivatives Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Artemisinin Derivatives Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Artemisinin Derivatives Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Artemisinin Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 36. Global Artemisinin Derivatives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Artemisinin Derivatives Revenue Market Share by Regions (2015-2020)
Figure 38. Global Artemisinin Derivatives Revenue Market Share by Regions in 2018
Figure 39. North America Artemisinin Derivatives Sales and Growth Rate (2015-2020)
Figure 40. Europe Artemisinin Derivatives Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Artemisinin Derivatives Sales and Growth Rate (2015-2020)
Figure 42. South America Artemisinin Derivatives Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Artemisinin Derivatives Sales and Growth Rate (2015-2020)
Figure 44. North America Artemisinin Derivatives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Artemisinin Derivatives Sales Market Share by Countries (2015-2020)
Figure 46. North America Artemisinin Derivatives Sales Market Share by Countries in 2018
Figure 47. North America Artemisinin Derivatives Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Artemisinin Derivatives Revenue Market Share by Countries in 2018
Figure 49. United States Artemisinin Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Canada Artemisinin Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Mexico Artemisinin Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Europe Artemisinin Derivatives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Artemisinin Derivatives Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Artemisinin Derivatives Revenue Market Share by Countries in 2019
Figure 55. Germany Artemisinin Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 56. UK Artemisinin Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 57. France Artemisinin Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Russia Artemisinin Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Italy Artemisinin Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Asia-Pacific Artemisinin Derivatives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Artemisinin Derivatives Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Artemisinin Derivatives Revenue Market Share by Regions 2019
Figure 63. China Artemisinin Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Japan Artemisinin Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Korea Artemisinin Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 66. India Artemisinin Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Southeast Asia Artemisinin Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 68. South America Artemisinin Derivatives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Artemisinin Derivatives Sales Market Share by Countries in 2019
Figure 70. South America Artemisinin Derivatives Revenue Market Share by Countries in 2019
Figure 71. Brazil Artemisinin Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Argentina Artemisinin Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Middle East and Africa Artemisinin Derivatives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Artemisinin Derivatives Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Artemisinin Derivatives Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Artemisinin Derivatives Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Artemisinin Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Egypt Artemisinin Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Turkey Artemisinin Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 80. South Africa Artemisinin Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Global Artemisinin Derivatives Sales and Growth Rate (2021-2025) (K MT)
Figure 82. Global Artemisinin Derivatives Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Artemisinin Derivatives Market Forecast (2021-2025) (K MT)
Figure 84. Europe Sales Artemisinin Derivatives Market Forecast (2021-2025) (K MT)
Figure 85. Asia-Pacific Sales Artemisinin Derivatives Market Forecast (2021-2025) (K MT)
Figure 86. South America Sales Artemisinin Derivatives Market Forecast (2021-2025) (K MT)
Figure 87. Middle East & Africa Sales Artemisinin Derivatives Market Forecast (2021-2025) (K MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel